- Report
- April 2025
- 50 Pages
Global
From €2505EUR$2,650USD£2,128GBP
- Report
- April 2021
China
From €2457EUR$2,600USD£2,088GBP
- Report
- April 2025
- 50 Pages
Global
From €2505EUR$2,650USD£2,128GBP
Bromhexine is a medication used to treat respiratory diseases such as bronchitis, asthma, and chronic obstructive pulmonary disease (COPD). It is an expectorant, meaning it helps to loosen and thin mucus in the lungs, making it easier to cough up. Bromhexine is available in tablet, syrup, and injection form. It is often used in combination with other medications to treat respiratory diseases.
Bromhexine is a widely used medication in the respiratory drugs market. It is used to treat a variety of respiratory diseases, and is available in multiple forms. It is often used in combination with other medications to treat respiratory diseases.
Some companies in the Bromhexine market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Boehringer Ingelheim. Show Less Read more